Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126923731 | 12692373 | 1 | I | 2015 | 20160809 | 20160828 | 20160828 | PER | US-ASTRAZENECA-2016SE86497 | ASTRAZENECA | 68.00 | YR | M | Y | 70.30000 | KG | 20160829 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126923731 | 12692373 | 1 | PS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | PULMICORT FLEXHALER 180MCG, 1 PUFF TWICE A DAY | U | 21949 | INHALATION POWDER | ||||||||
| 126923731 | 12692373 | 2 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | PULMICORT FLEXHALER 180MCG, 1 PUFF TWICE A DAY | U | 21949 | INHALATION POWDER | ||||||||
| 126923731 | 12692373 | 3 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | PULMICORT FLEXHALER 180MCG 1 PUFF DAILY | U | 21949 | INHALATION POWDER | ||||||||
| 126923731 | 12692373 | 4 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | PULMICORT FLEXHALER 180MCG 1 PUFF DAILY | U | 21949 | INHALATION POWDER | ||||||||
| 126923731 | 12692373 | 5 | C | FLUTICISONE | 2 | Nasal | 0 | 16 | G | QD | |||||||||
| 126923731 | 12692373 | 6 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 126923731 | 12692373 | 7 | C | ANORO ELLIPTA | UMECLIDINIUM BROMIDEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 0 | QD | ||||||||||
| 126923731 | 12692373 | 8 | C | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126923731 | 12692373 | 1 | Asthma |
| 126923731 | 12692373 | 2 | Chronic obstructive pulmonary disease |
| 126923731 | 12692373 | 3 | Asthma |
| 126923731 | 12692373 | 4 | Chronic obstructive pulmonary disease |
| 126923731 | 12692373 | 5 | Sinusitis |
| 126923731 | 12692373 | 6 | Lung disorder |
| 126923731 | 12692373 | 7 | Chronic obstructive pulmonary disease |
| 126923731 | 12692373 | 8 | Emergency care |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126923731 | 12692373 | Asthma-chronic obstructive pulmonary disease overlap syndrome | |
| 126923731 | 12692373 | Bronchial disorder | |
| 126923731 | 12692373 | Chronic sinusitis | |
| 126923731 | 12692373 | Dyspnoea | |
| 126923731 | 12692373 | General physical health deterioration | |
| 126923731 | 12692373 | Intentional product misuse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126923731 | 12692373 | 7 | 20160601 | 0 |